Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor

Tools

Item Type:	Article
Title:	Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor
Creators Name:	Dragun, D., Braesen, J.H., Schoenemann, C., Fritsche, L., Budde, K., Neumayer, H.H., Luft, F.C. and Wallukat, G.
Keywords:	Acute Disease, Adrenal Cortex Hormones, Angiotensin II Type 1 Receptor Blockers, Antibody Formation, Biopsy, Combination Drug Therapy, Cyclosporine, Graft Rejection, Imidazoles, Immunoglobulin G, Immunosuppressive Agents, Kidney Transplantation, Losartan, Major Histocompatibility Complex, Mycophenolic Acid, Pyridines, Type 1 Angiotensin Receptor
Source:	Transplantation Proceedings
ISSN:	0041-1345
Publisher:	Elsevier
Volume:	35
Number:	6
Page Range:	2104-2105
Date:	September 2003
Official Publication:	https://doi.org/10.1016/S0041-1345(03)00680-8
PubMed:	View item in PubMed

Repository Staff Only: item control page